Clinical Report: Development of the Endocrine Variant Extractor and Its Role
Overview
The Endocrine Variant Extractor (EVE) is a bioinformatics pipeline designed to streamline genetic screening for endocrine disorders. EVE identified a de novo GATA3 mutation in a patient with HDR syndrome.
Background
Genetic diagnosis in endocrine disorders often faces challenges due to the complexity of Whole Exome Sequencing (WES) data. The development of user-friendly bioinformatics tools is crucial for enhancing the diagnostic capabilities of clinicians.
Data Highlights
EVE filtered over 300,000 raw variants to identify actionable candidates, including a GATA3 frameshift variant in HDR syndrome.
Key Findings
EVE integrates multiple bioinformatics engines for variant analysis.
The pipeline reduces manual data review time by over 99.6%.
EVE encompasses a core panel of 26 genes and an expanded panel of 413 genes.
The first identified GATA3 frameshift variant (p.Ala173fs) in HDR syndrome was reported using EVE.
The complete source code for EVE is available for public use.
Clinical Implications
The EVE pipeline facilitates identification of pathogenic variants in endocrine disorders. Its design allows clinicians to utilize genetic profiling in diagnostics.
Conclusion
EVE enables efficient identification of clinically relevant variants and supports the integration of genomic data into clinical practice.
